CIFLAXIN

This brand name is authorized in Nigeria.

Active ingredients

The drug CIFLAXIN contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-8090	Ear/eye drops	CIFLAXIN STERILE EYE/EAR DROPS SOL_DROPS 3mg/mL X5ML	CIFLAXIN STERILE EYE/EAR DROPS CIPROFLOXACIN Ciprofloxacin HCL 0.70kg, Sodium Chloride 0.44kg, Disodium edetate 0.10kg, Benzalkonium chloride 95% 20.00g, Sodium acetate 5.00g, Acetic acid 2.00g, Water for injection to 200.00lts Apr-90 Drugs Nigerian Products X5ML POM 1 29/04/2022 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02
S03AA07	Ciprofloxacin	S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives
Discover more medicines within S03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-8090, A11-0996